Bioregenerative Aesthetic Injectables Market Outlook for Skin Rejuvenation
Bioregenerative Aesthetic Injectables Market Overview Valued at USD 1.6 billion in 2025, the bioregenerative aesthetic injectables market is projected to reach USD 1.7 billion in 2026 and USD 4.0 billion by 2034, growing at a CAGR of 11.3% during the forecast period 2026–2034. Key players include AbbVie Inc.; Croma-Pharma GmbH; Crown Laboratories, Inc.; Evolus, Inc.; Galderma S.A.; Hugel,...
0 Commenti 0 condivisioni 20 Views 0 Anteprima